- WHAT IS d4T?
- WHO SHOULD TAKE d4T?
- WHAT ABOUT DRUG RESISTANCE?
- HOW IS d4T TAKEN?
- WHAT ARE THE SIDE EFFECTS?
- HOW DOES d4T REACT WITH OTHER DRUGS?
this Fact Sheet on a single page using: |
|
|
|
More information on Downloading & Printing Fact Sheets |
d4T (Zerit®), is a drug used for antiviral
therapy. It is manufactured by Bristol-Myers Squibb. d4T is
also known as stavudine or didehydro-deoxythymidine.
d4T is a nucleoside analog reverse transcriptase inhibitor,
or nuke. These drugs block the reverse transcriptase enzyme. This
enzyme changes HIV’s genetic material (RNA) into the form of DNA.
This has to occur before HIV’s genetic code gets inserted into
an infected cell’s own genetic codes.
d4T?
d4T was approved as an antiviral drug for people with HIV infection.
There are no absolute rules about when to start antiviral drugs.
You and your doctor should consider your T-cell
count, your viral load,
any symptoms you are having, and your attitude about taking HIV
medications. Fact Sheet 411
has more information about guidelines
for the use of antiviral medications.
If you take d4T with other antiviral drugs, you can reduce
your viral load to extremely low levels, and increase your T-cell
counts. This should mean staying healthier longer.
RESISTANCE?
Many new copies of HIV are mutations. They are slightly different
from the original virus. Some mutations can keep multiplying even
when you are taking an antiviral drug. When this happens, the
drug will stop working. This is called “developing resistance”
to the drug. See Fact Sheet 414
for more information on resistance.
Sometimes, if your virus develops resistance to one drug, it
will also have resistance to other antiviral drugs. This is called
“cross-resistance”.
Resistance can develop quickly. It is very important to
take antiviral medications according to instructions, on schedule,
and not to skip or reduce doses.
d4T is available in capsules of 15mg, 20mg, 30mg, and 40mg.
The normal adult dose depends on body weight. If you weigh more
than 60 kilograms (132 pounds), the dose is 40 mg twice daily.
If you weigh less, the dose is 30 mg twice daily.
Be sure your doctor knows if you have had liver problems. Your
liver will have to be watched carefully if you take d4T, and your
doctor might decide that you should not use d4T at all.
SIDE EFFECTS?
When you start any anti?viral treatment, you may have temporary
side effects such as headaches, hypertension, or a general sense
of feeling ill. These side effects usually get better or disappear
over time.
The most serious side effects of d4T are peripheral
neuropathy, lipodystrophy
and lactic acidosis.
Peripheral neuropathy is a form of nerve damage. It
usually shows up as tingling, numbness, or a sharp burning sensation
in the feet, legs, or hands. The nerve damage is usually temporary
and will go away if you stop taking d4T, or reduce the dose. If
you continue to take d4T after nerve damage shows up, it may become
permanent. See Fact Sheet 555
for more information.
Lipodystrophy is a collection of changes in body shape
and blood chemistry. See Fact
Sheet 553 for more information. Several studies found that
d4T is strongly linked to the loss of fat in the legs, arms and
face. Many drugs seem to contribute to lipodystrophy and we don’t
fully understand how it occurs. However, some people are avoiding
d4T because of its link to lipodystrophy.
Lactic acidosis is a buildup of lactic acid in the blood.
This is a by-product of abnormal energy production by the cells.
It may be caused by damage to the mitochondria. See Fact
Sheet 556 for more information on mitochondrial
toxicity. Lactic acidosis can cause severe damage to the pancreas
and liver. Symptoms of lactic acidosis can include weight loss,
abdominal pain, and severe fatigue.
HOW
DOES d4T REACT WITH OTHER DRUGS?
d4T should not be taken with AZT (zidovudine, Retrovir®)
or ddC (zalcitabine, Hivid®).
d4T’s side effects may be worse if taken with ganciclovir
or pentamidine.
Pregnant women should not take d4T and ddI at the same
time due to an increased risk of lactic acidosis.
Revised November
11, 2002
to InfoNet Main Page
Index of Fact Sheets
here if you have questions
New Mexico AIDS Education and Training Center
and the New Mexico Department of Health